×
About 5,214 results

NHLBI's COVID-19 Guidance for Practicing Clinicians
https://www.nhlbi.nih.gov/coronavirus/nhlbi-covid-19-guidance-practicing-clinicians
NIH

Health care providers seeking information about appropriate coronavirus disease 2019 (COVID-19) treatment may now consult treatment guidelines developed by a panel of U.S. physicians, statisticians, and other experts. These guidelines are based on published and preliminary data and the clinical expertise of the panelists, many of whom are frontline clinicians caring for patients during the rapi...

CHEST Clinical Pulmonary Guidelines
https://www.chestnet.org/Guidelines-and-Resources/CHEST-Guideline-Topic-Areas/Clinical-Pulmonary

Conflicts of Interest in Research
https://www.ama-assn.org/delivering-care/ethics/conflicts-interest-research
AMA

Increasing numbers of physicians, both within and outside academic health centers, are becoming involved in partnerships with industry to conduct biomedical and health research. As they do so, physicians must be mindful of the conflicts such engagement poses to the integrity of the research and the welfare of human participants. In addition to financial conflicts of interest created by incentiv...

The COVID-19 Treatment Guidelines Panel’s Statement on the Use of Ivermectin for the Treatment of COVID-19
https://www.covid19treatmentguidelines.nih.gov/statement-on-ivermectin
National Institutes of Health (NIH)

The COVID-19 Treatment Guidelines Panel (the Panel) has determined that currently there are insufficient data to recommend either for or against the use of ivermectin for the treatment of COVID-19. Results from adequately powered, well-designed, and well-conducted clinical trials are needed to provide more specific, evidence-based guidance on the role of ivermectin for the treatment of COVID-19.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR THE CLINICAL USE OF...
https://www.aace.com/files/nutraceuticals-2003.pdf
AACE Nutrition Guidelines Task Force

Sep 30th, 2003 - This report will discuss alternative care medicine, introduce DS/N and define their nature, present a strategy for discussing DS/N with patients, provide a list of resources to peruse for further education, and review specific DS/N in detail based on levels of scientific substantiation. These guidelines differ from other extensive reviews on the topic by focusing on hormonal and metabolic agent.

A Framework for Addressing Multimorbidity in Clinical Practice Guidelines for Pulmonary Dise...
http://www.thoracic.org/statements/resources/research/multimorbidity.pdf
Kevin C. Wilson

Mar 2nd, 2016 - Coexistence of multiple chronic conditions (i. e.

ACR Appropriateness Criteria Nonvariceal Upper Gastrointestinal Bleeding
https://www.jacr.org/article/S1546-1440(17)30221-1/fulltext
Singh-Bhinder, N.

Apr 30th, 2017 - Upper gastrointestinal bleeding (UGIB) remains a significant cause of morbidity and mortality with mortality rates as high as 14%. This document addresses the indications for imaging UGIB that is nonvariceal and unrelated to portal hypertension.

An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bron...
http://www.thoracic.org/statements/resources/lts/BOS-CPG.pdf
Keith C. Meyer

Oct 29th, 2014 - Bronchiolitis obliterans syndrome (BOS) is a major complication of lung transplantation that is associated with poor survival. The International Society for Heart and Lung Transplantation, American Thoracic Society, and European Respiratory Society convened a committee of international experts to describe and/or provide recommendations for 1) the definition of BOS, 2) the risk factors for devel.

Alcoholic Liver Disease
https://www.aasld.org/sites/default/files/guideline_documents/AlcoholicLiverDisease1-2010.pdf
Robert S. O’Shea, Srinivasan Dasarathy et. al.

Dec 31st, 2009 - Alcoholic liver disease (ALD) encompasses a spectrum of injury, ranging from simple steatosis to frank cirrhosis. It may well represent the oldest form of liver injury known to humankind.

AMDA White Papers and Resolution & Position Statements
https://paltc.org/papers?field_paper_type_target_id=127&topic=All

All resolutions, policy papers, and position statements are submitted for consideration and endorsement by the House of Delegates.

Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clin...
http://ascopubs.org/doi/full/10.1200/JCO.18.01160
Burstein, H.

Nov 18th, 2018 - Purpose: To update the ASCO clinical practice guideline on adjuvant endocrine therapy based on emerging data about the optimal duration of aromatase inhibitor (AI) treatment. MethodsASCO conducted a systematic review of randomized clinical trials from 2012 to 2018.

An Update of Evaluation of Intravenous Sedation on Diagnostic Spinal Injection Procedures
http://www.painphysicianjournal.com/linkout?issn=1533-3159&vol=16&page=SE217
Howard S. Smith

Feb 19th, 2013 - Based on a review of the available evidence, it appears that the administration of mild to moderate sedation does not confound the results or diagnostic validity of spinal injection procedures. Specifically, immediate pain relief after cervical and lumbar facet joint controlled nerve blocks is not enhanced by IV sedation with midazolam or fentanyl.

An Update of the Systematic Appraisal of the Accuracy and Utility of Lumbar Discography in C...
http://www.painphysicianjournal.com/linkout?issn=1533-3159&vol=16&page=SE55

Mar 31st, 2013 - The intervertebral disc has been implicated as a major cause of chronic lumbar spinal pain based on clinical, basic science, and epidemiological research. There is, however, a lack of consensus regarding the diagnosis and treatment of intervertebral disc disorders.

American Osteopathic Association Guidelines for Osteopathic Manipulative Treatment (OMT) for...
http://jaoa.org/article.aspx?articleid=2538814
Richard J. Snow

Jul 31st, 2016 - The American Osteopathic Association (AOA) recommends that osteopathic physicians use osteopathic manipulative treatment (OMT) in the care of patients with low back pain. Evidence from systematic reviews and meta-analyses of randomized controlled trials (evidence level 1a, Table 1) supports this recommendation.

An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunother...
https://jitc.biomedcentral.com/articles/10.1186/s40425-018-0362-6
Sullivan, R.

May 29th, 2018 - Cancer immunotherapy has been firmly established as a standard of care for patients with advanced and metastatic melanoma. Therapeutic outcomes in clinical trials have resulted in the approval of 11 new drugs and/or combination regimens for patients with melanoma.

Antiviral Therapy for Chronic Hepatitis B Viral Infection in Adults: A Systematic Review and...
https://www.aasld.org/sites/default/files/Lok_et_al-2016-Hepatology.pdf
Anna S.F. Lok

Dec 31st, 2015 - Chronic hepatitis B viral (HBV) infection remains a significant global health problem. Evidence-based guidelines are needed to help providers determine when treatment should be initiated, which medication is most appropriate, and when treatment can safely be stopped.

Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (BPPV)
http://journals.sagepub.com/doi/full/10.1177/0194599816689667
Neil Bhattacharyya

Feb 28th, 2017 - This update of a 2008 guideline from the American Academy of Otolaryngology—Head and Neck Surgery Foundation provides evidence-based recommendations to benign paroxysmal positional vertigo (BPPV), defined as a disorder of the inner ear characterized by repeated episodes of positional vertigo. Changes from the prior guideline include a consumer advocate added to the update group, new evidence fr.

Defining Quality in Cardiovascular Imaging: A Scientific Statement From the American Heart A...
http://circimaging.ahajournals.org/content/10/12/e000017
Leslee J. Shaw

Dec 13th, 2017 - The aims of the current statement are to refine the definition of quality in cardiovascular imaging and to propose novel methodological approaches to inform the demonstration of quality in imaging in future clinical trials and registries.

Clinical Practice Guideline: Otitis Media with Effusion (OME)
http://journals.sagepub.com/doi/full/10.1177/0194599815623467
Richard M. Rosenfeld

Jan 31st, 2016 - This update of a 2004 guideline codeveloped by the American Academy of Otolaryngology—Head and Neck Surgery Foundation, the American Academy of Pediatrics, and the American Academy of Family Physicians, provides evidence-based recommendations to manage otitis media with effusion (OME), defined as the presence of fluid in the middle ear without signs or symptoms of acute ear infection. Changes f.

Cardiovascular Function and Treatment in Beta-Thalassemia Major
https://www.ahajournals.org/doi/abs/10.1161/CIR.0b013e31829b2be6?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Pennell, D.,et al.

Jun 30th, 2013 - This aim of this statement is to report an expert consensus on the diagnosis and treatment of cardiac dysfunction in ?-thalassemia major (TM). This consensus statement does not cover other hemoglobinopathies, including thalassemia intermedia and sickle cell anemia, in which a different spectrum of cardiovascular complications is typical.